2 completed, 1 suspended, 1 terminated, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Suspended 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow AGN 194204: new trials by email Literature Review of AGN 194204 trials Research Report on AGN 194204
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis IRX4204, Placebo - Psoriasis, Plaque Type Psorisis | Phase 2 | Suspended | Io Therapeutics | 20 | 2026-03-01 | 2026-03-03 |
| Study of IRX4204 for Treatment of Early Parkinson's Disease IRX4204 - Parkinson's Disease | Phase 1 | Completed | Io Therapeutics | 15 | 2014-08-01 | 2015-05-12 |
| Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer NRX 194204 - Castration Resistant Prostate Cancer | Phase 2 | Completed | Io Therapeutics | 38 | 2011-08-01 | 2021-05-14 |
| Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) NRX194204 - Non-small Cell Lung Cancer | Phase 2 | Unknown | NuRx Pharmaceuticals, Inc. | 48 | 2009-03-01 | 2009-09-03 |
| Oral NRX 194204 in Patients With Refractory Malignancies NRX 194204 - Refractory Malignancies | Phase 1 | Terminated | University of Southern California | 24 | 2008-02-01 | 2014-05-21 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasms (1) · Parkinson Disease (1) · Plaque, Amyloid (1) · Psoriasis (1)
Io Therapeutics (3) · NuRx Pharmaceuticals, Inc. (1) · University of Southern California (1)
United States (5)
Ken Marek, MD (1) · Lalita Pandit, MD (1)